Inactive Instrument

News ExpreS2ion Biotech Holding AB Nasdaq Stockholm

Equities

SE0008348262

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

ExpreS2ion resolves on a directed issue of units to guarantors in connection with the completed rights issue	Jul. 05	AQ
ExpreS2ion announces U.S. patent issue notification for glyco-engineered immunization antigens	Jul. 03	AQ
ExpreS2ion announces final outcome of its rights issue	Jul. 01	AQ
Rights issue subscription period ending 27 June 2024; subscription possible via form	Jun. 26	AQ
ExpreS2ion announces poster presentation on the use of glycoengineered Drosophila S2 cells for production of highly immunogenic antigens at the ESACT meeting	Jun. 24	AQ
Publication of clinical Phase Ib trial data for the adjuvanted RH5.1 blood-stage malaria vaccine	Jun. 21	AQ
ExpreS2ion hosts informative webinar on 2024 Rights Issue and Highlights Key Updates on HER2+ Breast Cancer Vaccine	Jun. 18	AQ
BioStock: Rights issue takes Expres2ion breast cancer vaccine to phase I	Jun. 14	AQ
ExpreS2ion CEO to BioStock: "Compelling preclinical package gives us confidence"	Jun. 12	AQ
The subscription period in ExpreS2ion's rights issue begins today	Jun. 12	AQ
ExpreS2ion to present in upcoming investor and scientific events	Jun. 10	AQ
ExpreS2ion publishes prospectus in connection with its rights issue of units	Jun. 05	AQ
Bulletin from the Annual General Meeting of ExpreS2ion Biotech Holding AB held on 5 June 2024	Jun. 05	AQ
ExpreS2ion Biotech : Interim report for January – March 2024 (Q1)	May. 16	PU
ExpreS2ion announces financial results for the first quarter of 2024	May. 16	AQ
ExpreS2ion Biotech Holding AB Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 16	CI
ExpreS2ion to present in spring investor events	May. 15	AQ
ExpreS2ion Biotech : Annual report 2023 including Auditor’s report	May. 08	PU
ExpreS2ion annual report for 2023 published	May. 08	AQ
Notice to attend the Annual General Meeting in ExpreS2ion Biotech Holding AB (publ)	May. 03	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News ExpreS2ion Biotech Holding AB Nasdaq Stockholm

Equities

SE0008348262

Summary

Filters